Fast Track Designation and $483 Million: Confirmed
Uncle Sam promised a vaccine by Election Day.
And today, nearly six months after the first confirmed case on U.S. soil, this may be the rest of the story behind that promise.
You see, production is now underway for a new breakthrough we call the “Super Vaccine.”
Already, in trials this viable response to COVID-19 has generated positive results in humans.
Now, here’s the kicker:
The FDA has granted the firm behind the vaccine a Fast-Track Designation.
Sure, this isn’t the ONLY biotech firm out there vying for immunization.
But they’re the only one the administration has infused with $483 million.
And the surge doesn’t stop there.
Right now, one billion doses are being fast-tracked.
And that’s just the beginning of a massive production effort.
Now, when all is said and done – the “Super Vaccine” could bring COVID-19 to its knees…
And it could also spark a staggering 58,300% revenue surge for one tiny company.
Critical: Do not wait on this until tomorrow.